IP Library Granted Patent US 10,407,428
Granted Patent B2
US 10,407,428 · App. 15/527,909 · Granted Sep 10, 2019

Spiro-isoquinoline-1,4′-piperidine compounds having multimodal activity against pain

Inventors: Carmen Almansa-Rosales (Barcelona, ES); Monica Garcia Lopez (Barcelona, ES); Ana-Maria Caamano-Moure (Santiago de Compostela, ES)
Assignee: ESTEVE PHARMACEUTICALS, S.A.
C07D471/10A61P25/04C07D471/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,407,428
App. No.
15/527,909
Granted
Sep 10, 2019
Kind
B2
Abstract

The present invention relates to spiro-isoquinoline-1,4′-piperidine compounds having dual pharmacological activity towards both the sigma (σ) receptor and the μ-opiod receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Claims (272)

1. A compound of general formula (I):

wherein

n is 0 or 1

R 1 is substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted alkylheterocyclyl, substituted or unsubstituted alkylcycloalkyl, —C(O)R 6 , —C(O)CH 2 OR 6 , —C(O)CH 2 OC(O)R 6 , —C(O)OR 6 , —C(O)NR 6 R 6′ or —S(O) 2 R 6 ;

wherein R 6 and R 6′ are independently selected from hydrogen, substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, substituted or unsubstituted aryl or substituted or unsubstituted alkylaryl, substituted or unsubstituted cycloalkyl or substituted or unsubstituted alkylcycloalkyl, substituted or unsubstituted heterocyclyl and substituted or unsubstituted alkyheterocylcyl;

R 2 is hydrogen, substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclyl, substituted or unsubstituted alkylcycloalkyl, substituted or unsubstituted alkylaryl, or substituted or unsubstituted alkylheterocyclyl;

wherein the alkyl, alkylene or alkynyl in R 2 , if substituted, is substituted with one or more substituent/s selected from —OR 12 , halogen, —CN, haloalkyl, haloalkoxy, —SR 12 , —S(O)R 12 , and —S(O) 2 R 12 ;

and wherein R 12 is selected from hydrogen, unsubstituted C 1-6 alkyl, and unsubstituted C 2-6 alkenyl, unsubstituted C 2-6 alkynyl;

X is selected from —CR x R x′ —, —CR x OR 14′ , —CR x R x′ NR 7 —, —CR x R x′ O—, —CR x R x′ NR 7 C(O)—, —C(O)—, —CR x R x′ C(O)—, —C(O)O—, —C(O)NR 7 —, —CR x R x′ C(O)NR 7 — and —C(O)NR 7 CR x R x′ —;

wherein R 7 is selected from hydrogen, substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, and Boc;

R x is selected from hydrogen, substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, —C(O)OR 14′ , —C(O)NR 14 R 14′ , —NR 14 C(O)R 14′ , and —NR 14 R 14′″ ;

R x′ is selected from hydrogen, substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl and substituted or unsubstituted C 2-6 alkynyl;

alternatively if X is —CR x R x′ —, R x and R x′ may form, together with the carbon atom to which they are attached, a substituted or unsubstituted heterocyclyl, or a substituted or unsubstituted cycloalkyl;

R 14 and R 14′ are independently selected from hydrogen, unsubstituted C 1-6 alkyl, unsubstituted C 2-6 alkenyl, unsubstituted C 2-6 alkynyl, and unsubstituted acetyl;

and wherein R 14′″ is selected from hydrogen, unsubstituted C 1-6 alkyl, unsubstituted C 2-6 alkenyl, unsubstituted C 2-6 alkynyl and -Boc;

R 3 is selected from hydrogen, halogen, —R 9 , —OR 9 , —NO 2 , —NR 9 R 9′″ , —NR 9 C(O)R 9′ , —NC(O)OR 9 , —NR 9 S(O) 2 R 9′ , —S(O) 2 NR 9 R 9′ , —NR 9 C(O)NR 9′ R 9″ , —SR 9 , —S(O)R 9 , —S(O) 2 R 9′ , —CN, haloalkyl, haloalkoxy, —C(O)OR 9 , —C(O)NR 9 R 9′ , —OCH 2 CH 2 OH, —NR 9 S(O) 2 NR 9′ R 9″ , —OCOR 9 , and C(CH 3 ) 2 OR 9 ;

R 3′ , R 3″ and R 3′″ are independently selected from hydrogen, halogen, —R 9 , —OR 9 , —NO 2 , —NR 9 R 9′″ , —NR 9 C(O)R 9′ , —NC(O)OR 9 , —NR 9 S(O) 2 R 9′ , —S(O) 2 NR 9 R 9′ , —NR 9 C(O)NR 9′ R 9″ , —SR 9 , —S(O)R 9 , —S(O) 2 R 9′ , —CN, haloalkyl, haloalkoxy, —C(O)OR 9 , —C(O)NR 9 R 9′ , —OCH 2 CH 2 OH, —NR 9 S(O) 2 NR 9′ R 9″ , —OCOR 9 , and C(CH 3 ) 2 OR 9 ;

wherein R 9 , R 9′ and R 9″ are independently selected from hydrogen, unsubstituted C 1-6 alkyl, unsubstituted C 2-6 alkenyl, unsubstituted C 2-6 alkynyl, and unsubstituted acetyl;

and wherein R 9′″ is selected from hydrogen, unsubstituted C 1-6 alkyl, unsubstituted C 2-6 alkenyl, unsubstituted C 2-6 alkynyl and -Boc;

R 4 is selected from hydrogen, —OR 13 , substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, —C(O)OR 13 , —C(O)NR 13 R 13′ , —NR 13 C(O)R 13′ , —NR 13 R 13′″ , —NC(O)OR 13 , and substituted or unsubstituted heterocyclyl;

R 4′ , is selected from hydrogen, or substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, and substituted or unsubstituted C 2-6 alkynyl;

wherein R 13 , R 13′ and R 13′″ are independently selected from hydrogen, unsubstituted C 1-6 alkyl, unsubstituted C 2-6 alkenyl, and unsubstituted C 2-6 alkynyl;

and wherein R 13′″ is selected from hydrogen, unsubstituted C 1-6 alkyl, unsubstituted C 2-6 alkenyl, unsubstituted C 2-6 alkynyl and -Boc;

R 5 and R 5′ are independently selected from hydrogen, or substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, and substituted or unsubstituted C 2-6 alkynyl;

optionally as a stereoisomer, a racemate, or in the form of a mixture of at least two of the stereoisomers, preferably stereoisomers, in any mixing ratio, or a corresponding salt thereof, or a corresponding solvate thereof.

2. The compound according to claim 1 , wherein

R 1 is —C(O)R 6 or —S(O) 2 R 6 .

3. The compound according to claim 1 , wherein

R 1 is substituted or unsubstituted C 1-6 alkyl.

4. The compound according to claim 1 , wherein

X is selected from —CR x R x′ NR 7 —, —CR x R x′ NR 7 C(O)—, —C(O)—, —C(O)O—, —C(O)NR 7 —, —CH 2 C(O)NR 7 —, —CR x R x′ O—, and —C(O)NR 7 CRxR x′ .

5. The compound according to claim 1 , wherein

X is, —CR x R x′ , —CR x OR 14′ , —CR x R x′ NR 7 —, or CR x R x′ O—, and

R 1 is —C(O)R 6 or —S(O) 2 R 6 .

6. The compound according to claim 1 , wherein

X is —CR x R x′ , —CR x OR 14′ , —CR x R x′ NR 7 —, or CR x R x′ O—, and

R 1 is substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl.

7. The compound according to claim 1 , wherein

X is —CR x R x′ , —CR x OR 14′ , —CR x R x′ NR 7 —, or CR x R x′ O—, and

R 1 is substituted or unsubstituted alkylaryl, substituted or unsubstituted alkylheterocyclyl, substituted or unsubstituted alkylcycloalkyl.

8. The compound according to claim 1 , wherein

X is —C(O)NR 7 —, and

R 1 is substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl.

9. The compound according to claim 1 , wherein

X is —C(O)—,

R 1 is substituted or unsubstituted C 1-6 alkyl, substituted or unsubstituted C 2-6 alkenyl, substituted or unsubstituted C 2-6 alkynyl, and

R 2 is substituted or unsubstituted heterocyclyl, wherein the heterocyclyl contains, at least, one nitrogen attached to the carbonyle group in X.

10. The compound according to claim 9 , wherein

R 1 is —C(O)R 6 or —S(O) 2 R 6 .

11. The compound according to claim 1 , which is selected from:

1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

2-methyl-1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)propan-1-one,

furan-2-yl(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)methanone,

1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)propan-1-one,

2-methoxy-1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

2-(benzyloxy)-1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(6-methoxy-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-morpholinoethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-((tetrahydro-2H-pyran-4-yl)methyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(methyl(phenyl)amino)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-isopropoxyethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-isobutyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone

1-(1′-(cyclohexylmethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(piperidin-1-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1, 4′-piperidine]-2-yl)ethanone,

1-(1′-isopentyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(benzyl(methyl)amino)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(pyridin-2-ylmethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(pyridin-2-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(pyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-phenoxyethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(pyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

3-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N,N-dimethylpropanamide,

1-(1′-(2-(6-(trifluoromethyl)pyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-ethoxyethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(2-(trifluoromethyl)pyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(3-fluoropyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(5-chloropyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

4-(2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)picolinonitrile,

1-(1′-(2-(5-fluoropyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(cyclopropymethoxy)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-isobutoxyethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(benzyloxy)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(cyclopropylmethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-morpholinoethanone,

3-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-methyl-N-phenylpropanamide,

1-(1′-(3-(trifluoromethoxy)phenethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

tert-butyl 2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethylcarbamate,

N-(3-(2(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)phenyl)acetamide,

2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-phenylethyl acetate,

1-(1′-(2-hydroxy-2-phenylethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-hydroxyethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(pyridin-2-yloxy)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(pyridin-3-yloxy)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(1′-(2-(pyridin-4-yloxy)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

N-(4-(2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)pyridin-2-yl)acetamide,

tert-butyl 2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl(methyl)carbamate,

1-(1′-(2-(methylamino)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

N-(2-(2-acetyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)-N-methylbenzamide,

2-acetyl-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-6-yl acetate,

1-(6-hydroxy-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1-(6-chloro-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

2-hydroxy-1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

2-(methylsulfonyl)-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

6-methoxy-2-methyl-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

N,N-diethyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1-yl)-1-(1,4-oxazepan-4-yl)ethanone,

1-(4-fluoropiperidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

1-(4-(2-hydroxypropan-2-yl)piperidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

1-(4-methoxypiperidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

1-(4,4-difluoropiperidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(6-azaspiro[2.5]octan-6-yl)ethanone,

2-ethyl-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-((1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)methyl)thiazole,

4-(2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)morpholine,

1′-(cyclohexylmethyl)-2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-((tetrahydro-2H-pyran-4-yl)methyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

N,N-dimethyl-3-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)propanamide,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-phenylethanone,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-morpholinoethanone,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(piperidin-1-yl)ethanone,

N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-phenylacetamide,

N,N-dimethyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

2-methyl-1′-(2-(tetrahydro-2H-pyran-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-(2-(pyridin-2-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-(2-(pyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

1′-(2-methoxyethyl)-2-methy-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

1′-(2-isopropoxyethyl)-2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-(2-(piperidin-1-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

4-(2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)morpholin-3-one,

N-methyl-3-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-phenylpropanamide,

2-methyl-1′-(pyridin-2-ylmethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-(pyridine-4-ylmethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-(pyridin-3-ylmethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-methyl-1′-(3-nitrophenethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

1-(4-fluoropiperidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)propan-1-one,

N-isobutyl-N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

1-(3,3-difluoropiperidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

N-ethyl-N-isopropyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyrrolidin-1-yl)ethanone,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(4-(trifluoromethyl)piperidin-1-yl)ethanone,

1-(3,3-difluoropyrrolidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

N-benzyl-N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

(S)-1-(3-fluoropyrrolidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

(R)-1-(3-fluoropyrrolidin-1-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyridin-3-yl)ethanol,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyridin-2-yl)ethanol,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyrindin-4-yl)ethanol,

(R)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyridin-4-yl)ethanol,

(S)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyridin-4-yl)ethanol,

N-(cyclopropylmethyl)-N-ethyl-2-(2-methy-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide

N,N-diisopropyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N-isopropyl-N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N-ethyl-N-isobutyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N-ethyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-propylacetamide,

N-cyclopropyl-N-ethyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N-isopropyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-propylacetamide,

N-isopropyl-N-(2-methoxyethyl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N-ethyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-(pentan-3-yl)acetamide

N-isobutyl-N-isopropyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1-yl)-N-(pentan-3-yl)acetamide,

N-(cyclopropylmethyl)-N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

1-(3-fluoropyridin-4-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanol,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(4-methylpiperidin-1-yl)ethanone,

1-((2S,6R)2,6-dimethylmorpholino)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

N-methyl-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-(pyridin-2-ylmethyl)acetamide,

3-(2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)aniline,

N-(3-(2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)phenyl)methanesulfonamide,

N-(3-(2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)phenyl)acetamide,

2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-phenylethanol,

2-methyl-1′-(2-(pyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-(2-methoxyethyl)-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanol,

2-(2-methoxyethyl)-1′-(2-(pyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

2-(1′-(2-(pyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanol,

2-(2-(2-hydroxyethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(piperidin-1-yl)ethanone,

2-(1′-(2-(5-fluoropyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanol,

2-(1′-(2-(5-(trifluoromethyl)pyridin-3-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanol,

2-(1′-(2-(pyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanol,

2-(1′-(2-(3-fluoropyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanol,

2-methyl-1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidin]-6-ol,

2,2,2-trifluoro-1-(1′-phenethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-yl)ethanone,

1′-phenethyl-2-(2,2,2-trifluoroethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

1-morpholino-2-(2-(2,2,2-trifluoroethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

1-(piperidin-1-yl)-2-(2-(2,2,2-trifluoroethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

1′-(2-(pyridin-4-yl)ethyl)2(2,2,2-trifluoroethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

1′-(2-(pyridin-3-yl)ethyl)-2-(2,2,2-trifluoroethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine],

1-(piperidin-1-yl)-2-(2,4,4-trimethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

1-(1′-phenethylspiro[isoindoline-1,4′-piperidine]-2-yl)ethanone,

2-methyl-1′-phenethylspiro[isoindoline-1,4′-piperidine],

2-methyl-1′-((tetrahydro-2H-pyran-4-yl)methyl)spiro[isoindoline-1,4′-piperidine],

(R)-1-(3-fluoropyridin-4-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1-yl)ethanol,

(S)-1-(3-fluoropyridin-4-yl)-2-(2-methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1-yl)ethanol,

N-ethyl-2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-isopropylacetamide,

1-(4,4-difluoropiperidin-1-yl)-2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(pyridin-4-yl)ethanol,

2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1-yl)-1-morpholinoethanone,

4-(2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethyl)morpholine,

2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(1,1-dioxo-thiomorpholin-4-yl)ethanone,

2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-1-(4-fluoropiperidin-1-yl)ethanone,

1-(3,3-difluoropiperidin-1-yl)-2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethanone,

2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N-methyl-N-(pentan-3-yl)acetamide,

2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)-N,N-dimethylacetamide,

N-cyclopropyl-N-ethyl-2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

N,N-diethyl-2-(2-ethyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)acetamide,

1-(4,4-difluoropiperidin-1-yl)-2-(2-methylspiro[isoindoline-1,4′-piperidine]-1′-yl)ethanone,

N-ethyl-N-isopropyl-2-(2-methylspiro[isoindoline-1,4′-piperidine]-1′-yl)acetamide,

N-ethyl-1′-(2-(pyridin-4-yl)ethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-2-carboxamide,

1′-(2-(Pyrimidin-5-yl)ethyl)-2-(2,2,2-trifluoroethyl)-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine], and

2-(2-(2-Methyl-3,4-dihydro-2H-spiro[isoquinoline-1,4′-piperidine]-1′-yl)ethylamino)ethanol.

12. A process for the preparation of a compound of Formula (I) according to claim 1 ,

wherein the process comprises

a) reacting a compound of formula IX with a suitable reagent of formula Xa-d, using different conditions depending on the reagent nature,

wherein,

n, R 1 , R 2 , R 3 , R 3′ , R 3″ , R 3′″ , R 4 and R 4′ are as defined in claim 1 for the compound of formula (I),

Xa is WCR 5 R 5′ XR 2 ,

Xb is O═CR 5 R 5′ XR 2 ,

Xc is CR 5 R 5′ ═CR x R 2 ,

Xd is CR 5 R 5′ OCR x R 2 ; and

W is a leaving group,

or

b) reacting a compound of formula XII with a reducing agent, in a suitable solvent, at a suitable temperature comprised between room temperature and the reflux temperature,

wherein,

n, X, R 1 , R 2 , R 3 , R 3′ , R 3″ , R 3′″ , R 4 and R 4′ are as defined in claim 1 for the compound of formula (I),

or

c) by reaction of intermediate XIV with Xa-d, followed by reaction with VIIa-h,

wherein,

n, R 1 , R 2 , R 3 , R 3′ , R 3″ , R 3′″ , R 4 and R 4′ are as defined in claim 1 for the compound of formula (I),

Xa is WCR 5 R 5′ XR 2 ,

Xb is O═CR 5 R 5′ XR 2 ,

Xc is CR 5 R 5′ ═CR x R 2 ,

Xd is CR 5 R 5′ OCR x R 2 ;

VIIa is R 1 ═O,

VIIb is R 1 W,

VIIc is R 6 COW,

VIId is (R 6 CO) 2 ,

VIIe is R 6 SO 2 W,

VIIf is R 6 NCO,

VIIg is R 6 NSO,

VIIh is R 6 COOW, and

W is a leaving group,

or

d) transforming intermediate XV by reduction with a reducing agent, in a suitable solvent, at a suitable temperature comprised between room temperature and the reflux temperature, followed by reaction with VIIa-h under the suitable conditions, or in the case where R 1 is alkyl, the step order can be inverted and compound I can be obtained by reaction of intermediate XV with VIIb under the suitable conditions, followed by reduction with a reducing agent, in a suitable solvent, at a suitable temperature comprised between room temperature and the reflux temperature,

wherein,

n, X, R 1 , R 2 , R 3 , R 3′ , R 3″ , R 3′″ , R 4 , R 4′ , R 5 and R 5′ are as defined in claim 1 for the compound of formula (I),

VIIa is R 1 ═O,

VIIb is R 1 W,

VIIc is R 6 COW,

VIId is (R 6 CO) 2 ,

VIIe is R 6 SO 2 W,

VIIf is R 6 NCO,

VIIg is R 6 NSO,

VIIh is R 6 COOW, and

W is a leaving group,

or

e) in the case where R 3 , R 3′ , R 3″ or R 3′″ is an electron donating group, compound I can also be prepared by reaction of a compound of formula VI with a compound of formula XVI in a suitable solvent, at a suitable temperature between 80 and 120°C. followed by reaction of with VIIa-h.

wherein,

n, R 1 , R 2 , R 3 , R 3′ , R 3″ , R 3′″ , R 4 , R 4′ , R 5 and R 5′ are as defined in claim 1 for the compound of formula (I),

VIIa is R 1 ═O,

VIIb is R 1 W,

VIIc is R 6 COW,

VIId is (R 6 CO) 2 ,

VIIe is R 6 SO 2 W,

VIIf is R 6 NCO,

VIIg is R 6 NSO,

VIIh is R 6 COOW, and

W is a leaving group.

13. A pharmaceutical composition which comprises the compound according to claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.

14. A method of treating pain in a subject in need thereof, comprising administration of an effective amount of the compound to said subject according to claim 1 .

15. The method according to claim 14 , wherein the pain is selected from medium to severe pain, visceral pain, chronic pain, cancer pain, migraine, inflammatory pain, acute pain, neuropathic pain, allodynia, and hyperalgesia.

16. The compound according to claim 1 , wherein the compound is in the form of an enantiomer or diastereomer.

17. The compound according to claim 1 , wherein the compound is in the form of a mixture of enantiomers and/or diastereomers, in any mixing ratio.

Assignments (2)
CHANGE OF NAME Recorded May 1, 2019
From: LABORATORIOS DEL DR. ESTEVE S.A.
To: ESTEVE PHARMACEUTICALS, S.A.
Reel/Frame 049837/0469 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2018
From: ALMANSA-ROSALES, CARMEN; GARCIA-LOPEZ, MONICA; CAAMANO-MOURE, ANA-MARIA
To: LABORATORIOS DEL DR. ESTEVE S.A.
Reel/Frame 045310/0125 →
Priority Claims (1)
EP 14382465 · Nov 21, 2014 · regional
Continuity (1)
Related Publication 20180111935A1 · Apr 26, 2018